17-63929137-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000626.4(CD79B):c.*89T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.62 in 897,194 control chromosomes in the GnomAD database, including 175,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.63 ( 30737 hom., cov: 33)
Exomes 𝑓: 0.62 ( 144604 hom. )
Consequence
CD79B
NM_000626.4 3_prime_UTR
NM_000626.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.285
Genes affected
CD79B (HGNC:1699): (CD79b molecule) The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-63929137-A-G is Benign according to our data. Variant chr17-63929137-A-G is described in ClinVar as [Benign]. Clinvar id is 1287682.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.666 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79B | NM_000626.4 | c.*89T>C | 3_prime_UTR_variant | 6/6 | ENST00000006750.8 | NP_000617.1 | ||
CD79B | NM_001039933.3 | c.*89T>C | 3_prime_UTR_variant | 6/6 | NP_001035022.1 | |||
CD79B | NM_001329050.2 | c.*89T>C | 3_prime_UTR_variant | 5/5 | NP_001315979.1 | |||
CD79B | NM_021602.4 | c.*89T>C | 3_prime_UTR_variant | 5/5 | NP_067613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79B | ENST00000006750.8 | c.*89T>C | 3_prime_UTR_variant | 6/6 | 1 | NM_000626.4 | ENSP00000006750 | P4 | ||
CD79B | ENST00000392795.7 | c.*89T>C | 3_prime_UTR_variant | 6/6 | 1 | ENSP00000376544 | A1 | |||
CD79B | ENST00000559358.1 | n.790T>C | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
CD79B | ENST00000698624.1 | n.776T>C | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes AF: 0.633 AC: 96113AN: 151876Hom.: 30721 Cov.: 33
GnomAD3 genomes
AF:
AC:
96113
AN:
151876
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.617 AC: 460053AN: 745200Hom.: 144604 Cov.: 10 AF XY: 0.612 AC XY: 242657AN XY: 396176
GnomAD4 exome
AF:
AC:
460053
AN:
745200
Hom.:
Cov.:
10
AF XY:
AC XY:
242657
AN XY:
396176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.633 AC: 96169AN: 151994Hom.: 30737 Cov.: 33 AF XY: 0.622 AC XY: 46235AN XY: 74276
GnomAD4 genome
AF:
AC:
96169
AN:
151994
Hom.:
Cov.:
33
AF XY:
AC XY:
46235
AN XY:
74276
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1609
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 36% of patients studied by a panel of primary immunodeficiencies. Number of patients: 34. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at